| HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control[Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPKTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPKTLVL | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥3000 |
| MICA (Glu24-Gln308)_x000D_ Accession # Q96QC4 | His | Avi |
| N-term | C-term |
[8 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥3500 |
| HLA-A*02:01&B2M&Survivin (LTLGEFLKL) Tetramer[ Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and LTLGEFLKL peptide] Accession # A0A140T913(HLA-A*02:01)&P61769(B2M)& LTLGEFLKL | His | Avi |
| N-term | C-term |
| 规格 | 价 格(¥) | 数量 | |
| ¥9900 |
| HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Monomer [Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M) and LMLGEFLKL peptide] Accession # A0A140T913(HLA-A*02:01)&P61769(B2M)&LMLGEFLKL | His | Avi |
| N-term | C-term |
[6 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥4500 |
| FcRn[Ser22-Ser297 (FCGRT) and Ile21-Met119 (B2M)] Accession # P01887 & Q61559 | His | Avi |
| N-term | C-term |
[6 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥5800 |
| FcRn [Ala24-Ser297 (FCGRT) and Ile21-Met119 (B2M)] Accession # Q8SPV9 (FCGRT) & Q8SPW0 (B2M) | His |
| N-term | C-term |
[10 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥3500 |
[2 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥1200 |
| HLA-A*02:01&B2M&GP100 (YLEPGPVTA) Monomer [Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and YLEPGPVTA peptide] Accession # A0A140T913(HLA-A*02:01)&P61769(B2M)&YLEPGPVTA | His | Avi |
| N-term | C-term |
[8 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥3000 |
| MICA (Glu24-Gln308) Accession # Q96QC4 | His | Avi |
| N-term | C-term |
[8 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥5800 |
| HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Tetramer[Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and RMFPNAPYL peptide] Accession # A0A140T913(HLA-A*02:01)&P61769(B2M)&RMFPNAPYL | His | Avi |
| N-term | C-term |
[8 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥9900 |